BioCorRx (BICX) Cash & Current Investments (2009 - 2026)
BioCorRx (BICX) posted Cash & Current Investments of $21,237 for Q2 2026, down 81.0% from $111,872 a year earlier and down 90.0% from the prior quarter.
Powered by 
Analysis
BioCorRx (BICX) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, BioCorRx's Cash & Current Investments came in at $139,360, up 58.3% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -25.1% (FY2020 to FY2025).
- In prior years, BioCorRx's Cash & Current Investments was $88,033 in FY2024 (+35.0%), $65,222 in FY2023 (-4.9%), $68,615 in FY2022 (-20.1%) and $85,838 in FY2021 (-85.5%).
- The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments since Q3 2024.
- On a year-over-year basis, Cash & Current Investments increased in three of the last six quarters, with growth averaging 102.3%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q1 2026, with growth of 777.8%; the weakest was Q3 2024, with a decline of 99.9%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $211,911 (Q1 2026), $139,360 (Q4 2025) and $287,688 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.27 Bn |
| 10 | BioCorRx | 830.00 | -906,148.00 | -56,997.00 | 21,237.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21,237.00 |
| Mar 31, 2026 | 211,911.00 |
| Dec 31, 2025 | 139,360.00 |
| Sep 30, 2025 | 287,688.00 |
| Jun 30, 2025 | 111,872.00 |
| Mar 31, 2025 | 24,142.00 |
| Dec 31, 2024 | 88,033.00 |
| Sep 30, 2024 | 90.00 |
| Jun 30, 2024 | 8,365.00 |
| Mar 31, 2024 | 101,080.00 |
| Dec 31, 2023 | 65,222.00 |
| Sep 30, 2023 | 156,409.00 |
| Jun 30, 2023 | 197,304.00 |
| Mar 31, 2023 | 203,687.00 |
| Dec 31, 2022 | 68,615.00 |
| Sep 30, 2022 | 63,529.00 |
| Jun 30, 2022 | 111,461.00 |
| Mar 31, 2022 | 213,166.00 |
| Dec 31, 2021 | 85,838.00 |
| Sep 30, 2021 | 745,457.00 |
API Access
BioCorRx Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();